U.S. Health officials have blocked the publication of a government study examining the effectiveness of updated COVID-19 vaccines, citing concerns about the research methodology used to assess the shots’ real-world impact.
The decision, announced by a spokesperson for the U.S. Department of Health and Human Services, prevents the findings from appearing in the Centers for Disease Control and Prevention’s Morbidity and Mortality Weekly Report, a key publication relied upon by healthcare providers and public health officials nationwide.
According to the spokesperson, the manuscript underwent multiple levels of scientific review but did not meet the agency’s standards for publication due to reservations about the analytical approach employed in estimating vaccine effectiveness.
Despite the hold, officials emphasized that the delay is part of a rigorous quality-control process designed to ensure that only research meeting the highest scientific criteria is released through official channels.
The withheld study had reportedly shown that the updated COVID-19 vaccines reduced emergency department visits and hospitalizations among healthy adults by approximately 50% during the previous winter season, based on earlier reporting by The Washington Post.
The controversy comes amid broader debates over U.S. Vaccine policy under Health Secretary Robert F. Kennedy Jr., whose tenure has been marked by shifting guidance and heightened scrutiny of immunization programs.
Public health experts note that timely access to vaccine effectiveness data remains critical for informing clinical recommendations and maintaining public confidence in immunization efforts, particularly as respiratory virus seasons continue to pose challenges.
